7,446.25

+44.25

+0.60%

51,780.00

+395.00

+0.77%

27,225.75

+140.50

+0.52%

Russell 2000 Futures

2,783.70

+23.20

+0.84%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,130.00

+55.10

+1.35%

74,865.40

-888.24

-1.17%

Crude Oil Dec 26

91.33

+0.50

+0.55%

US Private Equity

10,772.76

+11.83

+0.11%

OTC Markets OTCQB - Delayed Quote USD

Hydreight Technologies Inc. (HYDTF)

2.1050 +0.0650 (+3.19%)

At close: November 6 at 4:00:00 PM EST

Loading Chart for HYDTF

Chart Range Bar

Interval:

In partnership with ChartIQ

Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology

Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology

Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology

Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology

Hydreight Technologies Inc (HYDTF) (Q2 2026) Earnings Call Highlights: Record Revenue Surges ...

Hydreight Technologies Inc (HYDTF) (Q2 2026) Earnings Call Highlights: Record Revenue Surges ...

Hydreight Reports Record Q2 2026 Revenue of $28.0 Million, Net Income of $2.5 Million and Adjusted EBITDA of $3.2 Million

Hydreight Reports Record Q2 2026 Revenue of $28.0 Million, Net Income of $2.5 Million and Adjusted EBITDA of $3.2 Million

Hydreight Reports Record Q2 2026 Revenue of $28.0 Million, Net Income of $2.5 Million and Adjusted EBITDA of $3.2 Million

Hydreight Reports Record Q2 2026 Revenue of $28.0 Million, Net Income of $2.5 Million and Adjusted EBITDA of $3.2 Million

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston

Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston

Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston

Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston

Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations

Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations

Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations

Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations

Mobilize your Website

View Site in Mobile | Classic

Share by: